Helix BioMedix, Inc Company Profile

07:15 EDT 22nd September 2018 | BioPortfolio

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of synthetic bioactive peptides. Our patent estate covers six distinct classes of peptides, comprising more than 100,000 unique peptide sequences. Our primary commercial objective is to out-license proprietary peptides to entities that possess sales, marketing and/or manufacturing expertise. Our peptides appear to have both pharmaceutical as well as non-pharmaceutical uses including broad-spectrum topical anti-infectives, wound healing agents, anti-wrinkle/anti-aging additives for skin-care products and anti-bacterial adjuvants for oral care.


22122 20th Avenue SESuite 148
United States of America


Phone: 425.402.8400
Fax: 425.806.2999

News Articles [49 Associated News Articles listed on BioPortfolio]

Promega UK Announces Winners of the First Helix Sustainability Awards

Promega UK, the Life Sciences Company, based on the University of Southampton Science Park in Hampshire, has announced the winners of its first Helix Sustainability award. Helix is an onsite RFID (Rad...

ON Helix: Start-Up Café

ON Helix run by One Nucleus will be held on the 13th July. This year they’re introducing a new opportunity for start-ups to showcase themselves.

Helix receives approval to begin dosing in LDOS003 trial

Helix BioPharma has secured all necessary regulatory and ethics approvals to dose the first patient in its LDOS003 trial, due...Read More... The post Helix receives approval to begin dosing in LDOS003...

Helix Bets An 'App Store' Can Make Consumers Care About Their DNA

Helix, spun out of DNA sequencing giant Illumina, is a bet that consumers will be more interested in paying for access to their DNA one use at a time, while leaving their data sitting in perpetuity in...

Helix BioPharma Closes Private Placement

Helix BioPharma (TSX:HBP) an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for g...

Helix, ProMab sign LOI for cancer therapies

Helix BioPharma Corp. and ProMab Biotechnologies Inc. have signed a letter of intent for the development of chimeric antigen receptor T-cell (CART) therapies for hematological malignances and solid tu...

Helix Expands Real-World and Online Footprint with HumanCode Deal

Helix, which runs an online outlet for products based on customer DNA, has bought HumanCode, one of the app makers that contributes to its store. Denver-based HumanCode makes BabyGlimpse, which shows ...

Helix TCS Inc. (OTCQB: $HLIX) and BioTrackTHC Close Previously Announced Merger

Greenwood Village, Colorado - June 4, 2018 (Newsfile Corp.) ( Newswire) Helix TCS, Inc. (OTCQB: HLIX), in conjunction with its strategic capital partner, Rose Capital, is pleased to a...

PubMed Articles [192 Associated PubMed Articles listed on BioPortfolio]

Thermodynamics of the pseudo-knot in helix 18 of 16S ribosomal RNA.

A fragment of E. coli 16S rRNA formed by nucleotides 500 to 545 is termed helix 18. Nucleotides 505-507 and 524-526 form a pseudo-knot and its distortion affects ribosome function. Helix 18 isolated f...

Helix-loop-helix peptide foldamers and their use in the construction of hydrolase mimetics.

De novo designed helix-loop-helix peptide foldamers containing cis-2-aminocyclopentanecarboxylic acid residues were evaluated for their conformational stability and possible use in enzyme mimetic deve...

Not as easy as π: an insertional residue does not explain the π-helix gain-of-function in two component FMN reductases.

The π-helix located at the tetramer interface of two-component FMN-dependent reductases contributes to the structural divergence from canonical FMN-bound reductases within the NADPH:FMN reductase fam...

Tug-of-War in a Dynamic Helical Peptide: Solvent-Induced Helix-Helix Transition of a Lactam-Bridged Peptide Composed of Point- and Axial Chiralities Remote from Each Other.

The dynamic axial chirality of oligopeptide-bound 2,2'-bipyridine (bpy) residues can be remote-controlled and diastereoselectively locked. A right-handed (P)-310-helix is first induced in the dynamic ...

Mechanical unfolding reveals stable 3-helix intermediates in talin and α-catenin.

Mechanical stability is a key feature in the regulation of structural scaffolding proteins and their functions. Despite the abundance of α-helical structures among the human proteome and their undisp...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Phase I-II of Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers

The primary objective is to evaluate the efficacy and safety of the use of a formulation of snail slime and natural extracts, for the curative treatment of ulcer wonds in diabetic foot. ...

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)

The purpose of this study is to determine whether SYL1001 ophthalmic solution is safe and effective in the treatment of signs and symptoms of Dry Eye Disease.

Early Crossbite Correction - a Randomized Study

The aim of this longitudinal randomized investigation is to determine the long-term effects of early lateral crossbite correction with Quad-Helix appliance, during the deciduous dentition,...

Pressure Device in the Treatment of Ear Keloids

Keloids are benign cutaneous lesions, arising from proliferating fibroblasts. Keloids of the ear may occur after helix piercings and are difficult to treat, since they tend to form recurre...

Transcatheter Leak Closure With Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures

Although the clinical impact of left atrial appendage (LAA) leaks still requires confirmation, the open pouch with residual flow resulting from incomplete LAA closure may promote blood sta...

Companies [23 Associated Companies listed on BioPortfolio]

Helix BioMedix, Inc

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our co...

Helix BioMedix, Inc.

Helix BioMedix, Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of ...

Helix Therapeutics Inc

Helix Therapeutics Inc (Helix) is a privately held startup biotechnology company based in NewHaven, Connecticut. The company's proprietary technology was developed at the Yale University School of Med...

KS Biomedix Holdings Plc

KS Biomedix is a biopharmaceutical company with operations in the UK and Canada. It is developing small molecules and biologics for the in vivo diagnosis and treatment of cancer and inflammatory disea...


BioMedix is a new biotechnology company that specializes in developing and manufacturing high quality, high performance, cutting-edge ELISA assays. At BioMedix, we are committed to providing the most ...

More Information about "Helix BioMedix, Inc" on BioPortfolio

We have published hundreds of Helix BioMedix, Inc news stories on BioPortfolio along with dozens of Helix BioMedix, Inc Clinical Trials and PubMed Articles about Helix BioMedix, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Helix BioMedix, Inc Companies in our database. You can also find out about relevant Helix BioMedix, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record